Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Deckmyn

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
[Signal transduction in blood platelets]H Deckmyn
Cardiovascular Drugs and Therapy|February 1, 1992
Thromboxane synthase inhibitors and receptor antagonistsJ Vermylen, H Deckmyn
Archives Internationales De Physiologie Et De Biochimie|May 1, 1979
Stabilization of beta-lactoglobulin in alkaline medium by 2-p-toluidinylnaphthalene-6-sulphonate [proceedings]H Deckmyn, G Préaux
British Journal of Clinical Pharmacology|January 1, 1983
Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observationsJ Vermylen, H Deckmyn
Seminars in Thrombosis and Hemostasis|January 1, 1995
Functional effects of human antiplatelet antibodiesH Deckmyn, S De Reys
Plastic and Reconstructive Surgery|July 1, 1991
Thrombosis in injured small vesselsF Stockmans, H Deckmyn, J Vermylen
Blood|November 14, 1997
A platelet-activating antiglycoprotein Ib monoclonal antibodyH Deckmyn, K Vanhoorelbeke, N Cauwenberghs
Thrombosis Research|June 15, 1982
A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2G Defreyn, H Deckmyn, J Vermylen
Blood Reviews|September 1, 1995
Platelet activationD Blockmans, H Deckmyn, J Vermylen
Thrombosis and Haemostasis|September 24, 1999
The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2beta1(GPIa/IIa)-I-domain binding to collagen in a different mannerH Depraetere, A Kerekes, H Deckmyn
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
[Signal transduction in blood platelets]H Deckmyn
Cardiovascular Drugs and Therapy|February 1, 1992
Thromboxane synthase inhibitors and receptor antagonistsJ Vermylen, H Deckmyn
Archives Internationales De Physiologie Et De Biochimie|May 1, 1979
Stabilization of beta-lactoglobulin in alkaline medium by 2-p-toluidinylnaphthalene-6-sulphonate [proceedings]H Deckmyn, G Préaux
British Journal of Clinical Pharmacology|January 1, 1983
Reorientation of prostaglandin endoperoxide metabolism by a thromboxane synthetase inhibitor: in vitro and clinical observationsJ Vermylen, H Deckmyn
Seminars in Thrombosis and Hemostasis|January 1, 1995
Functional effects of human antiplatelet antibodiesH Deckmyn, S De Reys
Plastic and Reconstructive Surgery|July 1, 1991
Thrombosis in injured small vesselsF Stockmans, H Deckmyn, J Vermylen
Blood|November 14, 1997
A platelet-activating antiglycoprotein Ib monoclonal antibodyH Deckmyn, K Vanhoorelbeke, N Cauwenberghs
Thrombosis Research|June 15, 1982
A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2G Defreyn, H Deckmyn, J Vermylen
Blood Reviews|September 1, 1995
Platelet activationD Blockmans, H Deckmyn, J Vermylen
Thrombosis and Haemostasis|September 24, 1999
The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2beta1(GPIa/IIa)-I-domain binding to collagen in a different mannerH Depraetere, A Kerekes, H Deckmyn
Pageof 14